In Anderson–Fabry disease, the accumulation of sphingolipid substrates in lysosomes inhibits autophagosome–lysosome fusion and disrupts the mTOR activation/inactivation cycle, interfering with the mTOR-mediated control of mitochondrial metabolism [129]. This evidence concerns the gene MTOR and Fabry disease.